Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Longitudinal Molecular Magnetic Resonance Imaging of Endothelial Activation after Severe Traumatic Brain Injury.

Vegliante G, Tolomeo D, Drieu A, Rubio M, Micotti E, Moro F, Vivien D, Forloni G, Ali C, Zanier ER.

J Clin Med. 2019 Jul 30;8(8). pii: E1134. doi: 10.3390/jcm8081134.

2.

The immunological response to traumatic brain injury.

Needham EJ, Helmy A, Zanier ER, Jones JL, Coles AJ, Menon DK.

J Neuroimmunol. 2019 Jul 15;332:112-125. doi: 10.1016/j.jneuroim.2019.04.005. Epub 2019 Apr 11. Review.

PMID:
31005712
3.

Modelling human pathology of traumatic brain injury in animal models.

Risling M, Smith D, Stein TD, Thelin EP, Zanier ER, Ankarcrona M, Nilsson P.

J Intern Med. 2019 Jun;285(6):594-607. doi: 10.1111/joim.12909. Epub 2019 Apr 23.

PMID:
30963638
4.

Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials.

Carbonara M, Fossi F, Zoerle T, Ortolano F, Moro F, Pischiutta F, Zanier ER, Stocchetti N.

Front Neurol. 2018 Oct 24;9:885. doi: 10.3389/fneur.2018.00885. eCollection 2018. Review.

5.

Fluid Management in Acute Brain Injury.

Rossi S, Picetti E, Zoerle T, Carbonara M, Zanier ER, Stocchetti N.

Curr Neurol Neurosci Rep. 2018 Sep 11;18(11):74. doi: 10.1007/s11910-018-0885-8. Review.

PMID:
30206730
6.

Ultrasound-tagged near-infrared spectroscopy does not disclose absent cerebral circulation in brain-dead adults.

Caccioppola A, Carbonara M, Macrì M, Longhi L, Magnoni S, Ortolano F, Triulzi F, Zanier ER, Zoerle T, Stocchetti N.

Br J Anaesth. 2018 Sep;121(3):588-594. doi: 10.1016/j.bja.2018.04.038. Epub 2018 Jun 2.

7.

Induction of a transmissible tau pathology by traumatic brain injury.

Zanier ER, Bertani I, Sammali E, Pischiutta F, Chiaravalloti MA, Vegliante G, Masone A, Corbelli A, Smith DH, Menon DK, Stocchetti N, Fiordaliso F, De Simoni MG, Stewart W, Chiesa R.

Brain. 2018 Sep 1;141(9):2685-2699. doi: 10.1093/brain/awy193.

8.

Virtual Reality for Traumatic Brain Injury.

Zanier ER, Zoerle T, Di Lernia D, Riva G.

Front Neurol. 2018 May 16;9:345. doi: 10.3389/fneur.2018.00345. eCollection 2018.

9.

Placenta-Derived Cells for Acute Brain Injury.

Pischiutta F, Sammali E, Parolini O, Carswell HVO, Zanier ER.

Cell Transplant. 2018 Jan;27(1):151-167. doi: 10.1177/0963689717732992. Review.

10.

Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations.

Oddo M, Poole D, Helbok R, Meyfroidt G, Stocchetti N, Bouzat P, Cecconi M, Geeraerts T, Martin-Loeches I, Quintard H, Taccone FS, Geocadin RG, Hemphill C, Ichai C, Menon D, Payen JF, Perner A, Smith M, Suarez J, Videtta W, Zanier ER, Citerio G.

Intensive Care Med. 2018 Apr;44(4):449-463. doi: 10.1007/s00134-018-5086-z. Epub 2018 Mar 2. Review.

PMID:
29500701
11.

Human brain trauma severity is associated with lectin complement pathway activation.

De Blasio D, Fumagalli S, Orsini F, Neglia L, Perego C, Ortolano F, Zanier ER, Picetti E, Locatelli M, Stocchetti N, Longhi L, Garred P, De Simoni MG.

J Cereb Blood Flow Metab. 2019 May;39(5):794-807. doi: 10.1177/0271678X18758881. Epub 2018 Feb 9.

12.

Mesenchymal Stem Cell Therapy in Intracerebral Haemorrhagic Stroke.

Bedini G, Bersano A, Zanier ER, Pischiutta F, Parati EA.

Curr Med Chem. 2018;25(19):2176-2197. doi: 10.2174/0929867325666180111101410. Review.

PMID:
29332564
13.

Single severe traumatic brain injury produces progressive pathology with ongoing contralateral white matter damage one year after injury.

Pischiutta F, Micotti E, Hay JR, Marongiu I, Sammali E, Tolomeo D, Vegliante G, Stocchetti N, Forloni G, De Simoni MG, Stewart W, Zanier ER.

Exp Neurol. 2018 Feb;300:167-178. doi: 10.1016/j.expneurol.2017.11.003. Epub 2017 Nov 7.

14.

Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury.

Ercole A, Magnoni S, Vegliante G, Pastorelli R, Surmacki J, Bohndiek SE, Zanier ER.

Front Neurol. 2017 Aug 30;8:450. doi: 10.3389/fneur.2017.00450. eCollection 2017. Review.

15.

Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection.

Zoerle T, Carbonara M, Zanier ER, Ortolano F, Bertani G, Magnoni S, Stocchetti N.

Front Neurol. 2017 Jul 24;8:354. doi: 10.3389/fneur.2017.00354. eCollection 2017. Review.

16.

Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice.

Sammali E, Alia C, Vegliante G, Colombo V, Giordano N, Pischiutta F, Boncoraglio GB, Barilani M, Lazzari L, Caleo M, De Simoni MG, Gaipa G, Citerio G, Zanier ER.

Sci Rep. 2017 Jul 31;7(1):6962. doi: 10.1038/s41598-017-07274-w.

17.

Label-free monitoring of tissue biochemistry following traumatic brain injury using Raman spectroscopy.

Surmacki JM, Ansel-Bollepalli L, Pischiutta F, Zanier ER, Ercole A, Bohndiek SE.

Analyst. 2016 Dec 19;142(1):132-139.

18.

Macrophages are essential for maintaining a M2 protective response early after ischemic brain injury.

Perego C, Fumagalli S, Zanier ER, Carlino E, Panini N, Erba E, De Simoni MG.

Neurobiol Dis. 2016 Dec;96:284-293. doi: 10.1016/j.nbd.2016.09.017. Epub 2016 Sep 30.

PMID:
27697537
19.

Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites.

Pischiutta F, Brunelli L, Romele P, Silini A, Sammali E, Paracchini L, Marchini S, Talamini L, Bigini P, Boncoraglio GB, Pastorelli R, De Simoni MG, Parolini O, Zanier ER.

Crit Care Med. 2016 Nov;44(11):e1118-e1131.

PMID:
27441900
20.

Differential transgene expression patterns in Alzheimer mouse models revealed by novel human amyloid precursor protein-specific antibodies.

Höfling C, Morawski M, Zeitschel U, Zanier ER, Moschke K, Serdaroglu A, Canneva F, von Hörsten S, De Simoni MG, Forloni G, Jäger C, Kremmer E, Roßner S, Lichtenthaler SF, Kuhn PH.

Aging Cell. 2016 Oct;15(5):953-63. doi: 10.1111/acel.12508. Epub 2016 Jul 29.

21.

Chronic impact of traumatic brain injury on outcome and quality of life: a narrative review.

Stocchetti N, Zanier ER.

Crit Care. 2016 Jun 21;20(1):148. doi: 10.1186/s13054-016-1318-1. Review.

22.

Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury.

De Blasio D, Fumagalli S, Longhi L, Orsini F, Palmioli A, Stravalaci M, Vegliante G, Zanier ER, Bernardi A, Gobbi M, De Simoni MG.

J Cereb Blood Flow Metab. 2017 Mar;37(3):938-950. doi: 10.1177/0271678X16647397. Epub 2016 Jul 20.

23.

Internalization of nanopolymeric tracers does not alter characteristics of placental cells.

Bigini P, Zanier ER, Saragozza S, Maciotta S, Romele P, Bonassi Signoroni P, Silini A, Pischiutta F, Sammali E, Balducci C, Violatto MB, Talamini L, Garry D, Moscatelli D, Ferrari R, Salmona M, De Simoni MG, Maggi F, Simoni G, Grati FR, Parolini O.

J Cell Mol Med. 2016 Jun;20(6):1036-48. doi: 10.1111/jcmm.12820. Epub 2016 Mar 14.

24.

Clinical Results and Outcome Improvement Over Time in Traumatic Brain Injury.

Di Deo P, Lingsma H, Nieboer D, Roozenbeek B, Citerio G, Beretta L, Magnoni S, Zanier ER, Stocchetti N.

J Neurotrauma. 2016 Nov 15;33(22):2019-2025. Epub 2016 May 6.

PMID:
26943781
25.

Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke.

Zangari R, Zanier ER, Torgano G, Bersano A, Beretta S, Beghi E, Casolla B, Checcarelli N, Lanfranconi S, Maino A, Mandelli C, Micieli G, Orzi F, Picetti E, Silvestrini M, Stocchetti N, Zecca B, Garred P, De Simoni MG; LEPAS group.

J Neuroinflammation. 2016 Jan 20;13:16. doi: 10.1186/s12974-016-0481-2.

26.

Accuracy of intracranial pressure monitoring: systematic review and meta-analysis.

Zacchetti L, Magnoni S, Di Corte F, Zanier ER, Stocchetti N.

Crit Care. 2015 Dec 2;19:420. doi: 10.1186/s13054-015-1137-9. Review.

27.

Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury.

Papa S, Caron I, Erba E, Panini N, De Paola M, Mariani A, Colombo C, Ferrari R, Pozzer D, Zanier ER, Pischiutta F, Lucchetti J, Bassi A, Valentini G, Simonutti G, Rossi F, Moscatelli D, Forloni G, Veglianese P.

Biomaterials. 2016 Jan;75:13-24. doi: 10.1016/j.biomaterials.2015.10.015. Epub 2015 Oct 9.

PMID:
26474039
28.

Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia.

Llovera G, Hofmann K, Roth S, Salas-Pérdomo A, Ferrer-Ferrer M, Perego C, Zanier ER, Mamrak U, Rex A, Party H, Agin V, Fauchon C, Orset C, Haelewyn B, De Simoni MG, Dirnagl U, Grittner U, Planas AM, Plesnila N, Vivien D, Liesz A.

Sci Transl Med. 2015 Aug 5;7(299):299ra121. doi: 10.1126/scitranslmed.aaa9853.

PMID:
26246166
29.

Corrigendum: Versatility of the complement system in neuroinflammation, neurodegeneration, and brain homeostasis.

Orsini F, De Blasio D, Zangari R, Zanier ER, De Simoni MG.

Front Cell Neurosci. 2015 Jul 7;9:263. doi: 10.3389/fncel.2015.00263. eCollection 2015.

30.

Shape descriptors of the "never resting" microglia in three different acute brain injury models in mice.

Zanier ER, Fumagalli S, Perego C, Pischiutta F, De Simoni MG.

Intensive Care Med Exp. 2015 Dec;3(1):39. doi: 10.1186/s40635-015-0039-0. Epub 2015 Feb 24.

31.

Fractalkine Receptor Deficiency Is Associated with Early Protection but Late Worsening of Outcome following Brain Trauma in Mice.

Zanier ER, Marchesi F, Ortolano F, Perego C, Arabian M, Zoerle T, Sammali E, Pischiutta F, De Simoni MG.

J Neurotrauma. 2016 Jun 1;33(11):1060-72. doi: 10.1089/neu.2015.4041. Epub 2015 Sep 8.

32.

The ischemic environment drives microglia and macrophage function.

Fumagalli S, Perego C, Pischiutta F, Zanier ER, De Simoni MG.

Front Neurol. 2015 Apr 8;6:81. doi: 10.3389/fneur.2015.00081. eCollection 2015. Review.

33.

Neuroprotection in acute brain injury: an up-to-date review.

Stocchetti N, Taccone FS, Citerio G, Pepe PE, Le Roux PD, Oddo M, Polderman KH, Stevens RD, Barsan W, Maas AI, Meyfroidt G, Bell MJ, Silbergleit R, Vespa PM, Faden AI, Helbok R, Tisherman S, Zanier ER, Valenzuela T, Wendon J, Menon DK, Vincent JL.

Crit Care. 2015 Apr 21;19:186. doi: 10.1186/s13054-015-0887-8. Review.

34.

My paper 20 years later: cerebral venous oxygen saturation studied with bilateral samples in the internal jugular veins.

Stocchetti N, Magnoni S, Zanier ER.

Intensive Care Med. 2015 Mar;41(3):412-7. doi: 10.1007/s00134-015-3650-3. Epub 2015 Jan 23.

PMID:
25614058
35.

Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis.

Orsini F, De Blasio D, Zangari R, Zanier ER, De Simoni MG.

Front Cell Neurosci. 2014 Nov 7;8:380. doi: 10.3389/fncel.2014.00380. eCollection 2014. Review. Erratum in: Front Cell Neurosci. 2015;9:263.

36.

Intracranial pressure after subarachnoid hemorrhage.

Zoerle T, Lombardo A, Colombo A, Longhi L, Zanier ER, Rampini P, Stocchetti N.

Crit Care Med. 2015 Jan;43(1):168-76. doi: 10.1097/CCM.0000000000000670.

PMID:
25318385
37.

Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma.

Zanier ER, Pischiutta F, Riganti L, Marchesi F, Turola E, Fumagalli S, Perego C, Parotto E, Vinci P, Veglianese P, D'Amico G, Verderio C, De Simoni MG.

Neurotherapeutics. 2014 Jul;11(3):679-95. doi: 10.1007/s13311-014-0277-y.

38.

Ficolin-3-mediated lectin complement pathway activation in patients with subarachnoid hemorrhage.

Zanier ER, Zangari R, Munthe-Fog L, Hein E, Zoerle T, Conte V, Orsini F, Tettamanti M, Stocchetti N, Garred P, De Simoni MG.

Neurology. 2014 Jan 14;82(2):126-34. doi: 10.1212/WNL.0000000000000020. Epub 2013 Dec 11.

PMID:
24336142
39.

Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain.

Pischiutta F, D'Amico G, Dander E, Biondi A, Biagi E, Citerio G, De Simoni MG, Zanier ER.

Neuropharmacology. 2014 Apr;79:119-26. doi: 10.1016/j.neuropharm.2013.11.001. Epub 2013 Nov 15.

PMID:
24246661
40.

Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury.

Franke H, Parravicini C, Lecca D, Zanier ER, Heine C, Bremicker K, Fumagalli M, Rosa P, Longhi L, Stocchetti N, De Simoni MG, Weber M, Abbracchio MP.

Purinergic Signal. 2013 Sep;9(3):451-62. doi: 10.1007/s11302-013-9366-3. Epub 2013 Jun 26.

41.

Six-month ischemic mice show sensorimotor and cognitive deficits associated with brain atrophy and axonal disorganization.

Zanier ER, Pischiutta F, Villa P, Paladini A, Montinaro M, Micotti E, Orrù A, Cervo L, De Simoni MG.

CNS Neurosci Ther. 2013 Sep;19(9):695-704. doi: 10.1111/cns.12128. Epub 2013 Jun 7.

42.

Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients.

Zanier ER, Zoerle T, Fiorini M, Longhi L, Cracco L, Bersano A, Branca V, Benedetti MD, De Simoni MG, Monaco S, Stocchetti N.

Br J Anaesth. 2013 Sep;111(3):424-32. doi: 10.1093/bja/aet149. Epub 2013 May 5.

43.

Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor.

Longhi L, Perego C, Ortolano F, Aresi S, Fumagalli S, Zanier ER, Stocchetti N, De Simoni MG.

J Cereb Blood Flow Metab. 2013 Aug;33(8):1182-9. doi: 10.1038/jcbfm.2013.65. Epub 2013 Apr 24.

44.

Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.

Orsini F, Villa P, Parrella S, Zangari R, Zanier ER, Gesuete R, Stravalaci M, Fumagalli S, Ottria R, Reina JJ, Paladini A, Micotti E, Ribeiro-Viana R, Rojo J, Pavlov VI, Stahl GL, Bernardi A, Gobbi M, De Simoni MG.

Circulation. 2012 Sep 18;126(12):1484-94. doi: 10.1161/CIRCULATIONAHA.112.103051. Epub 2012 Aug 9.

45.

The genetics of small-vessel disease.

Bersano A, Debette S, Zanier ER, Lanfranconi S, De Simoni MG, Zuffardi O, Micieli G.

Curr Med Chem. 2012;19(24):4124-41. Review.

PMID:
22680632
46.

Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma.

Zanier ER, Montinaro M, Vigano M, Villa P, Fumagalli S, Pischiutta F, Longhi L, Leoni ML, Rebulla P, Stocchetti N, Lazzari L, De Simoni MG.

Crit Care Med. 2011 Nov;39(11):2501-10. doi: 10.1097/CCM.0b013e31822629ba.

PMID:
21725237
47.

Glial cells drive preconditioning-induced blood-brain barrier protection.

Gesuete R, Orsini F, Zanier ER, Albani D, Deli MA, Bazzoni G, De Simoni MG.

Stroke. 2011 May;42(5):1445-53. doi: 10.1161/STROKEAHA.110.603266. Epub 2011 Apr 7.

PMID:
21474800
48.

Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm.

Zanier ER, Brandi G, Peri G, Longhi L, Zoerle T, Tettamanti M, Garlanda C, Sigurtà A, Valaperta S, Mantovani A, De Simoni MG, Stocchetti N.

Intensive Care Med. 2011 Feb;37(2):302-9. doi: 10.1007/s00134-010-2075-2. Epub 2010 Nov 12.

PMID:
21072498
49.

Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage.

Zanier ER, Refai D, Zipfel GJ, Zoerle T, Longhi L, Esparza TJ, Spinner ML, Bateman RJ, Brody DL, Stocchetti N.

J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):157-9. doi: 10.1136/jnnp.2009.177667. Epub 2010 Jun 22.

50.

Recombinant C1 inhibitor in brain ischemic injury.

Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M, De Simoni MG.

Ann Neurol. 2009 Sep;66(3):332-42. doi: 10.1002/ana.21740.

PMID:
19798727

Supplemental Content

Loading ...
Support Center